NCEL
NewcelX Ltd.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$9.71M
P/E Ratio
—
EPS
$-6.55
Beta
0.57
52W High
$30.80
52W Low
$1.83
50-Day MA
$2.64
200-Day MA
$11.34
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About NewcelX Ltd.
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquartered in Zurich, Switzerland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-9.12M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -155.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-11.28 |
| Price-to-Book | 616.24 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.56M |
| Float | $2.01M |
| % Insiders | 71.31% |
| % Institutions | 4.16% |
Historical Volatility
HV 10-Day
138.53%
HV 20-Day
102.11%
HV 30-Day
86.41%
HV 60-Day
81.18%
HV Rank
45.2%
Volatility is currently expanding
Data last updated: 4/9/2026